TPA
ACHV icon

Trivium Point Advisory’s Achieve Life Sciences ACHV Stock Holding History

Trivium Point Advisory’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,750
Closed -$92K – 205
2022
Q1 		$92K Hold
11,750
– – 0.02% 218
2021
Q4 		$91K Sell
11,750
-50
-0.4% -$393 0.02% 238
2021
Q3 		$98K Buy
11,800
+450
+4% +$3.53K 0.02% 217
2021
Q2 		$102K Buy
11,350
+250
+2% +$2.38K 0.03% 208
2021
Q1 		$129K Buy
+11,100
New +$132K 0.03% 187

Other funds holding ACHV

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Trivium Point Advisory's ACHV Position: Q2 2022 in Review

Trivium Point Advisory sold out of Achieve Life Sciences (ACHV) in Q2 2022, closing a stake of 11,750 shares — an estimated $92K sold.

Trivium Point Advisory first reported a position in ACHV in Q1 2021 and held it in 5 quarters. The position peaked at $129K in Q1 2021. 31 funds tracked by Wall St. Rank hold ACHV as of Q2 2022.

  • Trivium Point Advisory reported no remaining Achieve Life Sciences position as of Q2 2022 after selling out during the quarter.
  • Trivium Point Advisory sold 11,750 Achieve Life Sciences shares in Q2 2022, an estimated $92K.
  • Trivium Point Advisory first reported a position in Achieve Life Sciences in Q1 2021 and held it in 5 quarters.
  • Trivium Point Advisory's Achieve Life Sciences position peaked at $129K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2022.

Based on Trivium Point Advisory's 13F filing for Q2 2022, filed 27 Jul 2022.